Matej Kosir, VNGOC: Welcome. Thank you for your great work during this difficult time of lack of access. Ambassador Dominika Krois, Chair: Welcome. Very happy to continue dialogue of Chairs with Civil Society, I’m aware of the important role you play and I appreciate it. Actis – Norwegian policy network on alcohol and drugs & …
From Civil Society Hearings and Informal Dialogues
Informal dialogue: UNODC Executive Director
Jamie Bridge, Chair, VNGOC: I’m Jamie bridge. I’m the chair of the Vienna NGO committee on drugs and we’re really grateful to Ms Ghada Waly and to other senior colleagues from UNODC for joining us today and for giving us this opportunity. These informal dialogues have been a regular part of the CND proceedings now …
Informal Dialogue with the INCB President
VNGOC: Welcome INCB president: We are committed to our continued dialogue. In the last 2 years, we engage with NGOs in the board’s session. The important role of CSOs is respectful of human rights and evidence base. CSOs are often the primary or main providers of services – we appreciate your work. Harm Reduction Australia: …
Informal Dialogue with the UNODC Executive Director
VNGOC: Ms. Waly could not make it. Jean Luc Lemahieu – UNODC: I had the fortune to be working as and working with civil society in my career. I welcome the fact that some 90 NGOs are attending CND and most of side vents are organized by you or with you. Civil society participation is …
Informal Dialogue with the CND Chair
Chair: We must involve civil society. We can’t do it alone. The problem effects individuals, groups and practically everyone in society. In all our countries, I could say, civil society is working more vibrantly than the governments. I am looking forward to a candid discussion today. Secretariat: Hello. We appreciate the relationship we were able …
Informal dialogue with the WHO
Lucía Goberna (VNGOC): Welcome Vladimir Pozniak (WHO): Thank you for being here, we hope this will become a tradition at CND. Kenzi Riboulet (FAAAT): There are three departments of WHO concerned with matters related to controlled drugs: Health products (EMP), Substance abuse (MSA), and Traditional/Complementary medicine (T&CM). What collaboration, coordination or cooperation exists between these …